首页> 外文期刊>Microbiology Insights >In Vitro Activity of Antimicrobial Agents Against Streptococcus Pyogenes Isolates from patients with Acute Tonsillopharyngitis in Dakar, Senegal
【24h】

In Vitro Activity of Antimicrobial Agents Against Streptococcus Pyogenes Isolates from patients with Acute Tonsillopharyngitis in Dakar, Senegal

机译:塞内加尔达喀尔患有急性扁桃体咽喉炎患者的抗脓生链球菌的抗菌药物的体外活性

获取原文
           

摘要

Streptococcus pyogenes (S. pyogenes) is the most important causative agent of tonsillopharyngitis. Beta-lactam antibiotics, particularly penicillin, are the drug of first choice and macrolides are recommended for patients who are allergic to penicillin. However, other antibiotics are also used for the treatment of streptococcal tonsillopharyngitis. In recent years, the increase in the incidence of respiratory tract pathogens that are resistant to current antibacterial agents highlights the need to monitor the evolution of the resistance of these pathogens to antibiotics. In this study, we assess the susceptibility of 98 isolates of S. pyogenes to 16 antibiotics. The pathogens were recovered from patients with acute tonsillopharyngitis in Dakar, the Senegalese capital city, who were recruited from May 2005 to August 2006. All strains were susceptible to penicillin with low Minimum Inhibitory Concentration (MIC = 0,016 mg/L). Amoxicillin had high activity (100%) showing its importance in treatment of streptococcal infections. Cephalosporins had MIC90 values ranging from 0.016 to 0.094 mg/L. Macrolides have shown high activity. All strains were resistant to tetracyclin. Other molecules such as teicoplanin, levofloxacin and chloramphenicol were also active and would represent alternatives to treatment of tonsillopharyngitis due to this pathogen. These results indicate that no significant resistance to antibiotics was found among patients with tonsillopharyngitis studied in Dakar. Limitations of this study were that the number of isolates tested was small and all isolates were collected from one hospital in Dakar. Hence, results may not be representative of the isolates found, in the wider community or other regions of Senegal. Further studies are needed in other parts of Dakar and other geographic regions of Senegal, in order to better clarify the antibiotic susceptibility profile of S. pyogenes isolates recovered from patients with tonsillopharyngitis.
机译:化脓性链球菌(S. pyogenes)是扁桃体咽喉炎最重要的病原体。 β-内酰胺类抗生素特别是青霉素是首选药物,对青霉素过敏的患者建议使用大环内酯类药物。但是,其他抗生素也可用于治疗链球菌扁桃体咽炎。近年来,对目前的抗菌剂有抗性的呼吸道病原体的发生率增加,凸显了需要监测这些病原体对抗生素的抗性的演变。在这项研究中,我们评估了98种化脓性链球菌对16种抗生素的敏感性。病原体是从塞内加尔首都达喀尔的急性扁桃体咽炎患者中回收的,该患者于2005年5月至2006年8月招募。所有菌株均对最低抑制浓度低(MIC = 0,016 mg / L)的青霉素敏感。阿莫西林具有很高的活性(100%),显示出其在治疗链球菌感染中的重要性。头孢菌素的MIC90值为0.016至0.094 mg / L。大环内酯类已显示出高活性。所有菌株均对四环素具有抗性。其他分子,例如替考拉宁,左氧氟沙星和氯霉素也有活性,由于这种病原体,它们可能代表扁桃体咽喉炎的替代治疗方法。这些结果表明在达喀尔研究的扁桃体咽喉炎患者中未发现对抗生素的显着耐药性。该研究的局限性在于所检测的分离株数量很少,并且所有分离株均从达喀尔的一家医院收集。因此,结果可能无法代表在塞内加尔更广泛的社区或其他地区发现的分离株。为了更好地阐明从扁桃体咽喉炎患者中回收的化脓性链球菌分离株的抗生素敏感性,需要在达喀尔其他地区和塞内加尔其他地理区域进行进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号